{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:35:50Z","timestamp":1793828150857,"version":"4.6.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.berh.2024.101975","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T09:58:22Z","timestamp":1723111102000},"page":"101975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Interferonopathies: From concept to clinical practice"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7533-1937","authenticated-orcid":false,"given":"Leonardo Oliveira","family":"Mendon\u00e7a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise","family":"Fr\u00e9mond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.berh.2024.101975_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2020.09.002","article-title":"COPA syndrome, 5 years after: where are we?","volume":"88","author":"Fr\u00e9mond","year":"2021","journal-title":"Joint Bone Spine"},{"issue":"5","key":"10.1016\/j.berh.2024.101975_bib3","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jaip.2024.02.013","article-title":"Anifrolumab to treat a monogenic interferonopathy","volume":"12","author":"Doroudchi","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.berh.2024.101975_bib4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","article-title":"The type I interferonopathies: 10 years on","volume":"22","author":"Crow","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.berh.2024.101975_bib5","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the international union of immunological Societies expert committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.berh.2024.101975_bib6","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI129301","article-title":"Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases","volume":"130","author":"de Jesus","year":"2020","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.berh.2024.101975_bib7","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/s12276-023-01118-6","article-title":"Understanding nucleic acid sensing and its therapeutic applications","volume":"55","author":"Kong","year":"2023","journal-title":"Exp Mol Med"},{"issue":"3","key":"10.1016\/j.berh.2024.101975_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4274\/balkanmedj.galenos.2023.2023-4-78","article-title":"Type I interferonopathies in childhood","volume":"40","author":"Ha\u015flak","year":"2023","journal-title":"Balkan Med J"},{"issue":"4","key":"10.1016\/j.berh.2024.101975_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.511","article-title":"cGAS-STING, an important signaling pathway in diseases and their therapy","volume":"5","author":"Li","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.berh.2024.101975_bib10","article-title":"A-to-I RNA editing by ADAR and its therapeutic applications: from viral infections to cancer immunotherapy","author":"Datta","year":"2023","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"1","key":"10.1016\/j.berh.2024.101975_bib11","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1038\/s41467-022-29946-6","article-title":"Deficiency in coatomer complex I causes aberrant activation of STING signalling","volume":"13","author":"Steiner","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.berh.2024.101975_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1287940","article-title":"Innate immune responses to RNA: sensing and signaling","volume":"15","author":"Luan","year":"2024","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.berh.2024.101975_bib13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.it.2016.12.004","article-title":"Crosstalk between cytoplasmic RIG-I and STING sensing pathways","volume":"38","author":"Zevini","year":"2017","journal-title":"Trends Immunol"},{"issue":"12","key":"10.1016\/j.berh.2024.101975_bib14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/intimm\/dxab037","article-title":"Dynamic control of nucleic-acid-sensing Toll-like receptors by the endosomal compartment","volume":"33","author":"Miyake","year":"2021","journal-title":"Int Immunol"},{"issue":"4","key":"10.1016\/j.berh.2024.101975_bib15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41577-021-00577-0","article-title":"Regulation of the nucleic acid-sensing Toll-like receptors","volume":"22","author":"Lind","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.berh.2024.101975_bib16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/s41590-024-01846-5","article-title":"Genetic variants in UNC93B1 predispose to childhood-onset systemic lupus erythematosus","volume":"25","author":"Al-Azab","year":"2024","journal-title":"Nat Immunol"},{"issue":"92","key":"10.1016\/j.berh.2024.101975_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adi9575","article-title":"Disrupted degradative sorting of TLR7 is associated with human lupus","volume":"9","author":"Mishra","year":"2024","journal-title":"Sci Immunol."},{"key":"10.1016\/j.berh.2024.101975_bib64","doi-asserted-by":"crossref","unstructured":"David C, Arango-Franco CA, Badonyi M, Fouchet J, Rice GI, Didry-Barca B, Maisonneuve L, Seabra L, Kechiche R, Masson C, Cobat A, Abel L, Talouarn E, B\u00e9ziat V, Deswarte C, Livingstone K, Paul C, Malik G, Ross A, Adam J, Walsh J, Kumar S, Bonnet D, Bodemer C, Bader-Meunier B, Marsh JA, Casanova JL, Crow YJ, Manoury B, Fr\u00e9mond ML, Bohlen J, Lepelley A. Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupus. J Exp Med. 2024 Aug 5;221(8):e20232066. doi: 10.1084\/jem.20232066. Epub 2024 Jun 13. PMID: 38869500; PMCID: PMC11176256.","DOI":"10.1084\/jem.20232066"},{"issue":"1","key":"10.1016\/j.berh.2024.101975_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108586","article-title":"A nuclear export signal is required for cGAS to sense cytosolic DNA","volume":"34","author":"Sun","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.berh.2024.101975_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1076784","article-title":"cGAS in nucleus: the link between immune response and DNA damage repair","volume":"13","author":"Song","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.berh.2024.101975_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/imr.13299","article-title":"Proteasome disorders and inborn errors of immunity","volume":"322","author":"Poli","year":"2024","journal-title":"Immunol Rev"},{"issue":"5","key":"10.1016\/j.berh.2024.101975_bib21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/annrheumdis-2021-221814","article-title":"The 2021 European Alliance of Associations for Rheumatology\/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE\/PRAAS, SAVI and AGS","volume":"81","author":"Cetin Gedik","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.berh.2024.101975_bib22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00109-016-1465-5","article-title":"Insights from mendelian interferonopathies: comparison of CANDLE, SAVI with AGS, monogenic lupus","volume":"94","author":"Kim","year":"2016","journal-title":"J Mol Med (Berl)."},{"issue":"2","key":"10.1016\/j.berh.2024.101975_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1183\/23120541.00017-2018","article-title":"Analysis of pulmonary features and treatment approaches in the COPA syndrome","volume":"4","author":"Tsui","year":"2018","journal-title":"ERJ Open Res"},{"issue":"10","key":"10.1016\/j.berh.2024.101975_bib24","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/art.40179","article-title":"Musculoskeletal disease in MDA5-related type I interferonopathy: a mendelian mimic of jaccoud's arthropathy","volume":"69","author":"de Carvalho","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2024.101975_bib25","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard-2022-223628","article-title":"EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice","volume":"82","author":"Rodr\u00edguez-Carrio","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.berh.2024.101975_bib27","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1084\/jem.20161451","article-title":"Detection of interferon alpha protein reveals differential levels and cellular sources in disease","volume":"214","author":"Rodero","year":"2017","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.berh.2024.101975_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002876","article-title":"Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider","volume":"9","author":"Burska","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2024.101975_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1421s92","article-title":"Measurement of type I interferon production","author":"Seeds","year":"2011","journal-title":"Curr Protoc Im"},{"issue":"3","key":"10.1016\/j.berh.2024.101975_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/pai.13400","article-title":"SIGLEC1 (CD169) as a potential diagnostical screening marker for monogenic interferonopathies","volume":"32","author":"Orak","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.berh.2024.101975_bib30","series-title":"Handbook of autoinflammatory diseases","first-page":"51","author":"Mendon\u00e7a","year":"2024"},{"issue":"6","key":"10.1016\/j.berh.2024.101975_bib37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated STING in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.berh.2024.101975_bib300","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s10875-024-01768-9","article-title":"SAVI study group","volume":"44","author":"de Becdeli\u00e8vre","year":"2024","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.berh.2024.101975_bib66","doi-asserted-by":"crossref","unstructured":"Crow Yj; AGS group. Clinical Non-penetrance Associated with Biallelic Mutations in the RNase H2 Complex. J Clin Immunol. 2023 May;43(4):706-708. doi: 10.1007\/s10875-023-01438-2. Epub 2023 Jan 27.PMID: 36705819.","DOI":"10.1007\/s10875-023-01438-2"},{"issue":"4","key":"10.1016\/j.berh.2024.101975_bib31","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s10875-021-01037-z","article-title":"Genetic mosaicism as a cause of inborn errors of immunity","volume":"41","author":"Aluri","year":"2021","journal-title":"J Clin Immunol"},{"issue":"12","key":"10.1016\/j.berh.2024.101975_bib32","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1474-4422(13)70258-8","article-title":"Assessment of interferon-related biomarkers in Aicardi-Gouti\u00e8res syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study","volume":"12","author":"Rice","year":"2013","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.berh.2024.101975_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0883073819870944","article-title":"Developmental outcomes of Aicardi gouti\u00e8res syndrome","volume":"35","author":"Adang","year":"2020","journal-title":"J Child Neurol"},{"issue":"7","key":"10.1016\/j.berh.2024.101975_bib34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri3850","article-title":"Aicardi-Gouti\u00e8res syndrome and the type I interferonopathies","volume":"15","author":"Crow","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.berh.2024.101975_bib35","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ajmg.a.36360","article-title":"Bilateral striatal necrosis in two subjects with Aicardi-Gouti\u00e8res syndrome due to mutations in ADAR1 (AGS6)","volume":"164A","author":"La Piana","year":"2014","journal-title":"Am J Med Genet"},{"issue":"3","key":"10.1016\/j.berh.2024.101975_bib36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0041-1739131","article-title":"Moyamoya syndrome in an infant with aicardi-gouti\u00e8res and williams syndromes: a case report","volume":"53","author":"Brar","year":"2022","journal-title":"Neuropediatrics"},{"issue":"3","key":"10.1016\/j.berh.2024.101975_bib38","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3390\/cells11030318","article-title":"Lung inflammation in STING-associated vasculopathy with onset in infancy (SAVI)","volume":"11","author":"David","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.berh.2024.101975_bib39","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3389\/fimmu.2017.00927","article-title":"CANDLE syndrome as a paradigm of proteasome-related autoinflammation","volume":"8","author":"Torrelo","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2024.101975_bib43","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.3389\/fimmu.2018.02496","article-title":"Monogenic lupus: a developing paradigm of disease","volume":"9","author":"Alperin","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2024.101975_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109699","article-title":"Monogenic lupus: tracing the therapeutic implications from single gene mutations","volume":"254","author":"Jia","year":"2023","journal-title":"Clin Immunol"},{"issue":"11","key":"10.1016\/j.berh.2024.101975_bib45","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00296-020-04653-x","article-title":"Monogenic lupus due to spondyloenchondrodysplasia with spastic paraparesis and intracranial calcification: case-based review","volume":"40","author":"Kara","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2024.101975_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.2011.06220.x","article-title":"Type I interferonopathies: a novel set of inborn errors of immunity","volume":"1238","author":"Crow","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.berh.2024.101975_bib46","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ng.3279","article-title":"COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis","volume":"47","author":"Watkin","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.berh.2024.101975_bib47","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fgene.2017.00118","article-title":"RIG-I-Like receptor signaling in singleton-merten syndrome","volume":"8","author":"Lu","year":"2017","journal-title":"Front Genet"},{"issue":"10","key":"10.1016\/j.berh.2024.101975_bib40","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.berh.2024.101975_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s42358-023-00303-5","article-title":"A brazilian nationwide multicenter study on deficiency of deaminase-2 (DADA2)","volume":"63","author":"Melo","year":"2023","journal-title":"Adv Rheumatol"},{"issue":"7","key":"10.1016\/j.berh.2024.101975_bib42","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s12519-022-00679-2","article-title":"Clinical spectrum and currently available treatment of type I interferonopathy Aicardi-Gouti\u00e8res syndrome","volume":"19","author":"Dell'Isola","year":"2023","journal-title":"World J Pediatr"},{"issue":"4","key":"10.1016\/j.berh.2024.101975_bib48","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jaci.2021.07.028","article-title":"JAK inhibition in the type I interferonopathies","volume":"148","author":"Crow","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.berh.2024.101975_bib49","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1172\/JCI121526","article-title":"JAK inhibitors in autoinflammation","volume":"128","author":"Hoffman","year":"2018","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.berh.2024.101975_bib53","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.berh.2024.101975_bib67","doi-asserted-by":"crossref","unstructured":"Vanderver A, Adang L, Gavazzi F, McDonald K, Helman G, Frank DB, Jaffe N, Yum SW, Collins A, Keller SR, Lebon P, Meritet JF, Rhee J, Takanohashi A, Armangue T, Ulrick N, Sherbini O, Koh J, Peer K, Besnier C, Scher C, Boyle K, Dubbs H, Kramer-Golinkoff J, Pizzino A, Woidill S, Shults J. Janus Kinase Inhibition in the Aicardi-Goutieres Syndrome. N Engl J Med. 2020 Sep 3;383(10):986-989. doi: 10.1056\/NEJMc2001362.PMID: 32877590.","DOI":"10.1056\/NEJMc2001362"},{"issue":"6","key":"10.1016\/j.berh.2024.101975_bib51","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s10875-023-01500-z","article-title":"JAK inhibition in aicardi-gouti\u00e8res syndrome: a monocentric multidisciplinary real-world approach study","volume":"43","author":"Fr\u00e9mond","year":"2023","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.berh.2024.101975_bib52","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/thoraxjnl-2019-213892","article-title":"Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhage","volume":"75","author":"Fr\u00e9mond","year":"2020","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.berh.2024.101975_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11926-020-00909-4","article-title":"Type I interferonopathies: from a novel concept to targeted therapeutics","volume":"22","author":"Melki","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.berh.2024.101975_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.717388","article-title":"Emerging place of JAK inhibitors in the treatment of inborn errors of immunity","volume":"12","author":"Hadjadj","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.berh.2024.101975_bib55","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40272-021-00457-z","article-title":"An update on the management of childhood-onset systemic lupus erythematosus","volume":"23","author":"Trindade","year":"2021","journal-title":"Paediatr Drugs"},{"issue":"4","key":"10.1016\/j.berh.2024.101975_bib56","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/art.37824","article-title":"Sifalimumab, a human anti-interferon-\u03b1 monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study","volume":"65","author":"Petri","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2024.101975_bib57","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/art.42392","article-title":"A randomized, placebo-controlled phase III extension trial of the long-term safety and tolerability of Anifrolumab in active systemic lupus erythematosus","volume":"75","author":"Kalunian","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"suppl 9","key":"10.1016\/j.berh.2024.101975_bib58","article-title":"Anifrolumab normalizes the type I interferon signature in a cohort of patients with type I interferonopathies [abstract]","volume":"75","author":"Alehashemi","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"23","key":"10.1016\/j.berh.2024.101975_bib59","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMc1810983","article-title":"Reverse-transcriptase inhibitors in the aicardi\u2013gouti\u00e8res syndrome","volume":"379","author":"Rice","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.berh.2024.101975_bib60","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41409-021-01378-8","volume":"56","author":"Lankester","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.berh.2024.101975_bib61","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/1744666X.2022.2078704","article-title":"Hematopoietic stem cell transplantation in systemic autoinflammatory diseases - the first one hundred transplanted patients","volume":"18","author":"Signa","year":"2022","journal-title":"Expet Rev Clin Immunol"},{"key":"10.1016\/j.berh.2024.101975_bib65","doi-asserted-by":"crossref","unstructured":"Cooray S, Henderson R, Solebo AL, Ancliffe P, Eleftheriou D, Brogan PA. Retinal vasculopathy in STING-associated vasculitis of infancy (SAVI). Rheumatology (Oxford). 2021 Oct 2;60(10):e351-e353. doi: 10.1093\/rheumatology\/keab297.","DOI":"10.1093\/rheumatology\/keab297"},{"issue":"8","key":"10.1016\/j.berh.2024.101975_bib62","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 car T-cell therapy in autoimmune disease - a case series with follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.berh.2024.101975_bib63","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.hoc.2022.03.011","article-title":"Genes as medicine: the development of gene therapies for inborn errors of immunity","volume":"36","author":"Long","year":"2022","journal-title":"Hematol Oncol Clin N Am"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T23:33:42Z","timestamp":1727134422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694224000469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1521694224000469"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2024.101975","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferonopathies: From concept to clinical practice","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2024.101975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101975"}}